tiprankstipranks
Advertisement
Advertisement

AU:ARX Stock Latest News

Aroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan
Company AnnouncementsAroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan
5d ago
ARX
Aroa Biosurgery strengthens US commercial leadership to drive global growth
PremiumCompany Announcements
Aroa Biosurgery strengthens US commercial leadership to drive global growth
5d ago
ARX
Aroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes
PremiumCompany Announcements
Aroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes
9d ago
ARX
Aroa Biosurgery Cuts Potential Dilution as Options and Rights Lapse
PremiumCompany Announcements
Aroa Biosurgery Cuts Potential Dilution as Options and Rights Lapse
19d ago
ARX
Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates
PremiumCompany Announcements
Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates
19d ago
ARX
Aroa Biosurgery CFO James Agnew Resigns After 13 Years of Service
PremiumCompany AnnouncementsAroa Biosurgery CFO James Agnew Resigns After 13 Years of Service
24d ago
ARX
Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
Premium
Company Announcements
Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
1M ago
ARX
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
Premium
Company Announcements
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
1M ago
ARX
Aroa Biosurgery director trims indirect shareholding in on-market sale
PremiumCompany Announcements
Aroa Biosurgery director trims indirect shareholding in on-market sale
1M ago
ARX
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
PremiumCompany Announcements
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
1M ago
ARX
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
PremiumCompany Announcements
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
2M ago
ARX
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
PremiumCompany Announcements
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
2M ago
ARX
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
PremiumCompany AnnouncementsAroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
3M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
Premium
Company Announcements
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
4M ago
ARX
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
Premium
Company Announcements
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
4M ago
ARX
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
PremiumCompany Announcements
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
4M ago
ARX
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
PremiumCompany Announcements
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
4M ago
ARX
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
PremiumCompany Announcements
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
6M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
PremiumCompany Announcements
Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
6M ago
ARX
Aroa Biosurgery Issues Investor-Focused February 2026 Business Update
PremiumCompany AnnouncementsAroa Biosurgery Issues Investor-Focused February 2026 Business Update
6M ago
ARX
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
Premium
Company Announcements
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
6M ago
ARX
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
Premium
Company Announcements
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
6M ago
ARX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >